Healthcare

David B. Lippman joined Paul Capital in 2000. As an Advisor, he helps develop sales projections for products under consideration for investment and monitors the performance of existing product investments made by Paul Capital Healthcare. Prior to joining Paul Capital, Mr. Lippman had a distinguished career spanning more than three decades as a highly rated sell-side analyst at Prudential Securities, Dean Witter and S.G. Warburg where he covered major U.S. pharmaceutical companies. He received his B.A. from the University of Michigan and his M.B.A. from the Columbia University School of Business. Mr. Lippman is also a Chartered Financial Analyst.